Design and Synthesis of Piperidine-3-carboxamides as Human

J.Med. Chen. 1995,38, 1416

1416

Add itions and Corrections 1994, Volume 37

Thomas R Bailey,* Guy D. Diana,John P. Mallamo, Niraqjan Vescio, Tandy L. Draper, Philip M. Carabateas, Melody k Long, Vincent L. Giranda, Frank J. Dutko, and Daniel C. Pevear: An Evaluation of the Antirhinoviral Activity of Acylfuran Replacements for 3-Methylisoxazoles. Are 2-Acetylfurans Bioisosteres for 3-Methylisoxazoles?. Page 4179. In Figure 4, the structure for 16a should have five methylenes in the connecting chain, not the six as shown in the paper. The correct structure is shown below:

1Sa

Page 4181. The structure shown at the top of Table 4 has a nonsensical heterocyclic ring and should correctly appear as shown below:

JM950097D

1995, Volume 38

Xiaozhang Zheng, S o m a R. Salgia, Walter B. Thompson, Elwood 0. Dillingham, Stephen E. Bond, Zixia Feng, K. Ram Prasad, and Ram Gollamudi*: Design and Synthesis of Piperidine-3-carboxamides as Human Platelet Aggregation Inhibitors. Page 181. In Table 1, the heading for the second column should be R , not X. A n additional footnote to Table 1 should read as follows: R, R = Et for all compounds. Page 182. In Table 2, the heading for the third column should be Cs-substituent, not R. In Table 3, the fifth column head should be N-substituent, not R. JM950100T

0022-262319511838-1416$09.00/00 1995 American Chemical Society